Do rectal suppositories (e.g., mesalamine or corticosteroid formulations) cause pain and cramping in ulcerative colitis?

Rectal Suppositories and Pain/Cramping in Ulcerative Colitis

Rectal suppositories (mesalamine or corticosteroid) are generally well-tolerated in ulcerative colitis, but patients with active disease may experience discomfort, particularly with enemas, while suppositories are better retained and cause less discomfort than liquid enema formulations. 1

Tolerability Profile by Formulation

Mesalamine Suppositories

• Mesalamine suppositories are generally well-tolerated with few treatment-related adverse effects and superior retention compared to enemas. 1
• Suppositories have a minimal side-effect profile and are better tolerated than enema formulations, making them the preferred choice for ulcerative proctitis. 2
• In clinical trials, mesalamine suppositories demonstrate safety in short-term use without significant treatment-related adverse events. 1

Corticosteroid Suppositories

• Rectal corticosteroid preparations are generally safe in studies of induction therapy, with second-generation corticosteroids like budesonide having very low risk (<1%) of adrenocortical axis suppression. 1
• Budesonide foam has a better patient tolerance profile compared to enema formulations, though specific data on suppository-related pain is limited. 2
• Short-term topical corticosteroid therapy carries a low overall risk of systemic side effects. 1

Active Disease and Discomfort

The key clinical consideration is that patients with active inflammation are more likely to experience discomfort:

• Patients with active disease, particularly those with prominent proctitis symptoms, may experience discomfort with rectal formulations and have difficulty retaining enemas adequately. 1
• In patients with active distal colitis, retaining enemas may be difficult due to urgency and rectal inflammation. 1, 3
• Some patients may tolerate foam preparations with less discomfort and improved retention compared to suppositories or enemas. 1

Comparative Tolerability

Suppositories vs. Enemas

• Foam formulations are preferred by patients over enemas because of easier delivery, better tolerability, and improved retention. 1
• Patients generally prefer oral administration over rectal therapy and want to reserve rectal therapy as adjunct during acute flares, indicating baseline reluctance but not necessarily pain-related intolerance. 1
• Suppositories are better retained than enemas and have superior patient tolerance, which is critically important for adherence. 4

Clinical Pitfalls to Avoid

Before attributing treatment failure or intolerance to the suppository itself:

• Assess for proximal constipation with abdominal X-ray, as fecal loading can impair drug delivery and cause treatment failure that may be misinterpreted as intolerance. 4, 5
• Verify medication adherence and proper administration technique before declaring treatment failure or intolerance. 4, 5
• Consider that difficulty with retention may reflect disease severity rather than formulation intolerance—active inflammation causes urgency that impairs retention. 3

Alternative Formulations for Intolerant Patients

If a patient cannot tolerate one rectal formulation, alternative options exist:

• For patients unable to retain liquid enemas, foam formulations offer comparable efficacy with better tolerance. 1
• Patients who are refractory to or intolerant of mesalamine suppositories may benefit from rectal corticosteroid foam preparations. 1
• Even for proctosigmoiditis extending beyond the rectum, suppositories provide meaningful benefit by treating the rectal component when enemas cannot be tolerated. 4